Cargando…
Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis
Systemic sclerosis (SSc) is manifested by fibrosis, vasculopathy and immune dysregulation. So far, a unifying hypothesis underpinning these pathological events remains unknown. Given that SSc is a multifactorial disease caused by both genetic and environmental factors, we focus on the two transcript...
Autores principales: | Noda, Shinji, Asano, Yoshihide, Nishimura, Satoshi, Taniguchi, Takashi, Fujiu, Katsuhito, Manabe, Ichiro, Nakamura, Kouki, Yamashita, Takashi, Saigusa, Ryosuke, Akamata, Kaname, Takahashi, Takehiro, Ichimura, Yohei, Toyama, Tetsuo, Tsuruta, Daisuke, Trojanowska, Maria, Nagai, Ryozo, Sato, Shinichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268882/ https://www.ncbi.nlm.nih.gov/pubmed/25504335 http://dx.doi.org/10.1038/ncomms6797 |
Ejemplares similares
-
Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma
por: Takahashi, Takehiro, et al.
Publicado: (2017) -
Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1
por: Akamata, Kaname, et al.
Publicado: (2014) -
Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells
por: Saigusa, Ryosuke, et al.
Publicado: (2018) -
A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis
por: Noda, Shinji, et al.
Publicado: (2012) -
Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in scleroderma
por: Miura, Shunsuke, et al.
Publicado: (2021)